We are live on ! Find out more
LP

Longview Partners Portfolio holdings

AUM $7.06B
1-Year Est. Return 3.43%
This Fund
S&P 500
This Quarter Est. Return
+4.12%
1 Year Est. Return
-3.43%
3 Year Est. Return
+28.48%
5 Year Est. Return
+46.59%
10 Year Est. Return
+218.87%
AUM
$12.9B
AUM Growth
+$822M
Cap. Flow
+$372M
Cap. Flow %
2.89%
Top 10 Hldgs %
56.19%
Holding
24
New
3
Increased
4
Reduced
15
Closed
2

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$668M
2
UNH icon
UnitedHealth
UNH
+$437M
3
OMC icon
Omnicom Group
OMC
+$41.8M
4
BNY
Bank of New York Mellon
BNY
+$25.9M
5
AVT icon
Avnet
AVT
+$10.7M

Top Sells

Rank Stock Value
1
DNB
Dun & Bradstreet
DNB
+$338M
2
LLL
L3 Technologies, Inc.
LLL
+$325M
3
LH icon
Labcorp
LH
+$71.7M
4
APTV icon
Aptiv
APTV
+$14.1M
5
ORCL icon
Oracle
ORCL
+$7.39M

Sector Composition

Rank Sector Weight
1 Technology 31.16%
2 Healthcare 25.43%
3 Financials 21.41%
4 Consumer Discretionary 11.23%
5 Communication Services 10.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APTV icon
1
Aptiv
APTV
$12.3B
$778M 6.04%
11,460,623
-221,350
-2% -$14.1M
ORCL icon
2
Oracle
ORCL
$339B
$761M 5.91%
18,601,411
-194,070
-1% -$7.39M
HCA icon
3
HCA Healthcare
HCA
$91.8B
$739M 5.74%
14,076,797
-72,230
-0.5% -$3.59M
FIS icon
4
Fidelity National Information Services
FIS
$23.9B
$729M 5.66%
13,639,861
-91,910
-0.7% -$4.9M
BNY
5
Bank of New York Mellon
BNY
$104B
$727M 5.65%
20,609,324
+783,196
+4% +$25.9M
COV
6
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$707M 5.49%
9,599,579
-64,520
-0.7% -$4.5M
AON icon
7
Aon
AON
$80.4B
$705M 5.48%
8,367,699
-63,120
-0.7% -$5.25M
WFC icon
8
Wells Fargo
WFC
$258B
$704M 5.47%
14,157,422
-138,160
-1% -$6.44M
VIAB
9
DELISTED
Viacom Inc. Class B
VIAB
$697M 5.41%
8,202,446
-58,300
-0.7% -$4.96M
TEL icon
10
TE Connectivity
TEL
$60.1B
$687M 5.33%
11,403,121
-128,480
-1% -$7.37M
AMGN icon
11
Amgen
AMGN
$210B
$679M 5.27%
+5,505,968
New +$668M
FISV
12
Fiserv Inc
FISV
$29.6B
$678M 5.26%
23,904,400
-170,340
-0.7% -$4.87M
ACN icon
13
Accenture
ACN
$106B
$675M 5.25%
8,471,050
-49,340
-0.6% -$4.05M
PFE icon
14
Pfizer
PFE
$144B
$673M 5.23%
22,073,935
-195,401
-0.9% -$5.83M
YUM icon
15
Yum! Brands
YUM
$42B
$668M 5.19%
12,317,133
+8,986
+0.1% +$473K
TWX
16
DELISTED
Time Warner Inc
TWX
$648M 5.03%
10,344,642
-15,155
-0.1% -$951K
TFC icon
17
Truist Financial
TFC
$64.5B
$620M 4.82%
15,435,743
-174,240
-1% -$6.67M
UNH icon
18
UnitedHealth
UNH
$385B
$476M 3.7%
+5,810,030
New +$437M
ARW icon
19
Arrow Electronics
ARW
$10.4B
$184M 1.43%
3,101,670
+62,461
+2% +$3.4M
AVT icon
20
Avnet
AVT
$6.87B
$180M 1.4%
3,868,191
+249,420
+7% +$10.7M
LLL
21
DELISTED
L3 Technologies, Inc.
LLL
$118M 0.92%
999,896
-2,909,399
-74% -$325M
OMC icon
22
Omnicom Group
OMC
$23.7B
$41.3M 0.32%
+568,907
New +$41.8M
LH icon
23
Labcorp
LH
$25.4B
-913,244
Closed -$71.7M
DNB
24
DELISTED
Dun & Bradstreet
DNB
-2,750,389
Closed -$338M

Similar funds

Longview Partners's Q1 2014 Portfolio in Review

As of Q1 2014, Longview Partners held 24 positions worth $12.9B, up 6.8% from $12.1B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Longview Partners's Q1 2014 filing shows 3 new, 4 increased, 15 reduced and 2 closed positions. Its largest new stake was Amgen: 5,505,968 shares worth $679M. The largest sale was Dun & Bradstreet, an estimated $338M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 35% a quarter earlier, followed by Healthcare and Financials.

  • Longview Partners's largest Q1 2014 buy was Amgen: 5,505,968 shares worth $679M.
  • Longview Partners added most to Bank of New York Mellon in Q1 2014, an estimated $25.9M increase.
  • Longview Partners's biggest Q1 2014 reduction was L3 Technologies, Inc., cutting an estimated $325M.
  • Longview Partners fully exited Dun & Bradstreet in Q1 2014, selling an estimated $338M.
  • Longview Partners's ten largest holdings make up 56% of its $12.9B portfolio in Q1 2014.
  • Longview Partners opened 3 new positions and closed 2 in Q1 2014.
  • Longview Partners's portfolio value rose 6.8% quarter-over-quarter to $12.9B.

Based on Longview Partners's 13F filing for Q1 2014, filed 1 May 2014.